These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8299120)

  • 1. Soluble factors produced by macrophages/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures.
    Kuppen PJ; Eggermont AM; Quak RB; Marinelli A; van de Velde CJ; Fleuren GJ
    Cancer Immunol Immunother; 1994 Jan; 38(1):61-7. PubMed ID: 8299120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of lymphokine-activated killer activity in rat splenocyte cultures: the importance of 2-mercaptoethanol and indomethacin.
    Kuppen PJ; Eggermont AM; Marinelli A; de Heer E; van de Velde CJ; Fleuren GJ
    Cancer Immunol Immunother; 1991; 33(1):28-32. PubMed ID: 2021956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of macrophages on interleukin-2 (IL-2)- and IL-4-induced murine lymphokine-activated killer activity.
    Tunru IS; Suzuki H; Yano S
    Int J Cancer; 1991 Jun; 48(4):568-73. PubMed ID: 2045201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokine-activated killer induction and its regulation by macrophages in malignant pleural effusions.
    Yanagawa H; Sone S; Nii A; Fukuta K; Nakanishi M; Maeda K; Honda M; Ogura T
    Jpn J Cancer Res; 1989 Dec; 80(12):1220-7. PubMed ID: 2516849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of human blood monocytes in up-regulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565.
    Sodhi A; Basu S
    Nat Immun; 1992; 11(2):105-16. PubMed ID: 1498519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monocytes inhibit lymphokine-activated killer cell expansion in vitro.
    Triozzi PL; Aldrich WA; Rinehart JJ
    Mol Biother; 1991 Mar; 3(1):22-5. PubMed ID: 2069757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of murine lymphokine (rIL-2)-activated killer cell activity by indomethacin.
    Chao TY; Ohnishi H; Chu TM
    Mol Biother; 1989; 1(6):318-22. PubMed ID: 2610950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma.
    Chao TY; Ohnishi H; Chu TM
    Immunology; 1990 May; 70(1):116-20. PubMed ID: 2113034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide exposure inhibits induction of lymphokine-activated killer cells by inducing precursor apoptosis.
    Samlowski WE; Yim CY; McGregor JR
    Nitric Oxide; 1998; 2(1):45-56. PubMed ID: 9706742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 from macrophages of murine splenocyte cultures inhibits the generation of lymphokine-activated killer cell activity.
    Ohnishi H; Lin TH; Nakajima I; Chu TM
    Tumour Biol; 1991; 12(2):99-110. PubMed ID: 2028183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lymphokine-activated killer (LAK) cells: III. Effect of L-phenylalanine methyl ester on LAK cell activation from human peripheral blood mononuclear cells: possible protease involvement of monocytes, natural killer cells and LAK cells.
    Leung KH
    Cancer Immunol Immunother; 1991; 34(1):31-6. PubMed ID: 1760808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of granulocyte-macrophage colony-stimulating factor on lymphokine-activated killer cell induction.
    Stewart-Akers AM; Cairns JS; Tweardy DJ; McCarthy SA
    Blood; 1993 May; 81(10):2671-8. PubMed ID: 8490177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of human monocyte function against Candida albicans by autologous IL-2-induced lymphokine-activated killer cells.
    Wei S; Serbousek D; McMillen S; Blanchard DK; Djeu JY
    J Immunol; 1991 Jan; 146(1):337-42. PubMed ID: 1898605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.
    Rahman MU; Mazumder A
    J Clin Immunol; 1992 Jul; 12(4):281-8. PubMed ID: 1355096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat Kupffer cell-derived nitric oxide modulates induction of lymphokine-activated killer cell.
    Kurose I; Miura S; Saito H; Tada S; Fukumura D; Higuchi H; Ishii H
    Gastroenterology; 1995 Dec; 109(6):1958-68. PubMed ID: 7498662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lymphokine-activated killer cells generation in vitro by soluble factors released from mixed human tumor and peripheral blood mononuclear adherent cells culture.
    Eisenthal A; Barbarsteyn E; Gitstein G; Lifschitz-Mercer B
    Cancer Invest; 2006 Feb; 24(1):28-34. PubMed ID: 16466989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells.
    Sone S; Inamura N; Singh SM; Okubo A; Yanagawa H; Nakanishi M; Ogura T
    Jpn J Cancer Res; 1989 Jul; 80(7):662-9. PubMed ID: 2507489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J; Gulati SC
    Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced human lymphokine-activated killer cell function after brief exposure to granulocyte-macrophage-colony stimulating factor.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Beroukas C; Stathopoulos GP; Papamichail M
    Cancer; 1995 Oct; 76(7):1253-60. PubMed ID: 8630906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.